Copper selective 8-aminoquinoline based tetradentate chelators as anticancer agents

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Angiogenesis, crucial for cancer growth and metastasis, is influenced by copper levels.
• Tetradentate monoquinoline (TDMQ) ligands are designed to precisely regulate copper homeostasis.
• Copper homeostasis plays a significant role in cancer progression.

Purpose of the Study:

• To evaluate the anticancer potential of the TDMQ20 chelator.
• To investigate the mechanism of action of TDMQ20 in human cancer cells.
• To compare the efficacy and selectivity of TDMQ20 against 5-fluorouracil.

Main Methods:

• In vitro testing of TDMQ20 on various human cancer cell lines.
• Comparative analysis with the reference drug 5-fluorouracil.
• Assessment of selectivity using non-cancer human cells.
• Investigation of cellular mechanisms including reactive oxygen species production, mitochondrial damage, and apoptosis induction.

Main Results:

• TDMQ20 demonstrated potent inhibition of cancer cell proliferation and migration.
• The chelator exhibited superior efficacy and selectivity compared to 5-fluorouracil.
• TDMQ20 induced intracellular reactive oxygen species, mitochondrial damage, and apoptosis in tumor cells.
• The drug's activity is linked to copper homeostasis restoration and redox modulation.

Conclusions:

• TDMQ20 shows significant promise as an anticancer drug candidate.
• Its mechanism involves copper-dependent redox modulation and induction of cancer cell death.
• TDMQ20 represents a potential therapeutic strategy for various human cancers.